Why the study?
No established treatment guidelines exist for cases of coexisting chronic thromboembolic pulmonary hypertension and localized lung cancer requiring surgery.
Intensification of CTEPH treatment with riociguat and balloon pulmonary angioplasty successfully improved pulmonary hemodynamics, enabling safe surgical resection of coexisting primary lung cancer.
Answers are grounded in this paper and cite their sources.
Supports individualized therapy in CTEPH with lung cancer; leaves open optimal sequencing and guidelines.
The basic treatment for chronic thromboembolic pulmonary hypertension (CTEPH) includes lifelong anticoagulant therapy and pulmonary endarterectomy; moreover, balloon pulmonary angioplasty (BPA) and vasodilators are also known to be effective. Surgery is the standard treatment for localized lung cancer. However, no established treatment guidelines exist for cases of coexisting CTEPH and lung cancer. The patient was a 55-year-old woman who experienced dyspnea on exertion. She was diagnosed with non-small cell lung cancer, and surgery was scheduled; however, she was also diagnosed with CTEPH during preoperative examinations. She was referred to our hospital, where right heart catheterization revealed a mean pulmonary artery pressure (mPAP) of 39 mmHg. We prioritized the treatment of CTEPH, starting oral riociguat followed by BPA three times. The mPAP decreased to 27 mmHg. Then, right upper lobectomy and lymph node dissection were performed. After surgery, there was no significant worsening of right heart failure, and no recurrence of the lung cancer. This case report presents a method for managing both CTEPH and primary lung cancer. The essence was the intensification of CTEPH treatment in anticipation of lobectomy.
No takes yet. Share an insight, caveat, or question.
Isomatsu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: